Congenital growth hormone deficiency

1 trials MedDRA PT
1 Registered trials
0 Recruiting
1 Unique sponsors
1 Unique IMPs
1 Commercial trials
Drug classes (ATC)
— ATC code not specified 1
Mechanism of action (INN-stem analysis)
Unknown / small molecule 1 substance
Phase III: 1

Filter these 1 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 1 trials

Phase III

1 trial
  • Lumos Pharma Inc. Commercial
    IBUTAMOREN MESILATE
    2025-523820-26-00 5 countries n=57 Orphan
    Not authorised
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Lumos Pharma Inc. Commercial 1 Phase III 0
← All indication landscapes